Hims & Hers launched an artificial intelligence agent embedded in its platform to help interpret biomarker lab results and ...
TAMPA, Fla.--(BUSINESS WIRE)--Verséa Health, Inc. (“Verséa”), a Florida-based health care company engaged in the commercialization of innovative diagnostics and therapeutics, has launched the Verséa ...
SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE: A) today announced its clinical informatics platform Alissa Interpret has been adopted by the North West Genomic Laboratory Hub ...
Constitutional genetic information is constant throughout life; patients are typically tested once in their lifetime and the test may never be repeated or confirmed. Consequently, incorrect results ...
Coagulation testing methodologies are often challenging for new users to understand. Terminology may be confusing and the methodologies are sensitive to many variables. Consideration of biological, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results